BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
DTSTART:20120325T030000
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:CEST
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20111030T020000
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:CET
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20260505T192253Z
UID:5004045275663@ist.ac.at
DTSTART:20120227T163000
DTEND:20120227T173000
DESCRIPTION:Speaker: Andrew Read\nAbstract: Resistance against antimicrobia
 l drugs is one of the major challenges to 21st century\nmedicine. There ar
 e two ways to fight resistance evolution. First\, discover and\ndeploy new
  drugs. Second\, use drugs wisely\, for example in combination therapy.\nS
 uch wise-use strategies are among humanitys largest efforts to inten
 tionally\nmanage the evolution of any organism. A resistance management st
 rategy widely\nadvocated by professional bodies\, medical schools and publ
 ic health authorities is to\nensure very high cure rates through full adhe
 rence to correct dosing regimens. I will\npropose that this resistance man
 agement strategy may be promoting the very\nevolution it is designed to re
 tard. There is a need for evidence-based resistance\nmanagement strategies
 \, and I will discuss how these might be developed.
LOCATION:Raiffeisen Lecture Hall\, Central Building\, ISTA
ORGANIZER:ihetzenauer@ist.ac.at
SUMMARY:Andrew Read: Institute Colloquium: The evolution of drug resistance
  and the curious orthodoxy of a
URL:https://talks-calendar.ista.ac.at/events/450
END:VEVENT
END:VCALENDAR
